CardioGenics Stock Forecast, Price & News

-0.01 (-27.78 %)
(As of 08/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume21,020 shs
Average Volume304,209 shs
Market Capitalization$3.09 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive CGNH News and Ratings via Email

Sign-up to receive the latest news and ratings for CardioGenics and its competitors with MarketBeat's FREE daily newsletter.

CardioGenics logo

About CardioGenics

CardioGenics Holdings, Inc. is a biotechnology company, which engages in the business of development and commercialization of diagnostic test products to the In Vitro Diagnostics testing market. Its products include QL Care Analyzer, Immunoassay Tests and Paramagnetic Beads. The company was founded by Yahia A. Gawad on November 20, 1997 and is headquartered in Mississauga, Canada.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.33 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

CardioGenics (OTCMKTS:CGNH) Frequently Asked Questions

What stocks does MarketBeat like better than CardioGenics?

Wall Street analysts have given CardioGenics a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but CardioGenics wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting CardioGenics?

CardioGenics saw a decrease in short interest in the month of June. As of June 30th, there was short interest totaling 8,600 shares, a decrease of 89.5% from the June 15th total of 82,200 shares. Based on an average daily volume of 228,700 shares, the short-interest ratio is currently 0.0 days.
View CardioGenics' Short Interest

How has CardioGenics' stock price been impacted by COVID-19 (Coronavirus)?

CardioGenics' stock was trading at $0.01 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, CGNH stock has increased by 160.0% and is now trading at $0.0260.
View which stocks have been most impacted by COVID-19

Who are CardioGenics' key executives?

CardioGenics' management team includes the following people:
  • Yahia A. Gawad, Chief Executive Officer & Director
  • James A. Essex, Chief Financial Officer
  • Linda J. Sterling, Secretary, Director & Head-Legal Affairs

Who are some of CardioGenics' key competitors?

What other stocks do shareholders of CardioGenics own?

Based on aggregate information from My MarketBeat watchlists, some companies that other CardioGenics investors own include Trinity Biotech (TRIB), Rock Creek Pharmaceuticals (RCPIQ), CEL-SCI (CVM) and (CGC).

What is CardioGenics' stock symbol?

CardioGenics trades on the OTCMKTS under the ticker symbol "CGNH."

How do I buy shares of CardioGenics?

Shares of CGNH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CardioGenics' stock price today?

One share of CGNH stock can currently be purchased for approximately $0.03.

How much money does CardioGenics make?

CardioGenics has a market capitalization of $3.09 million.

How many employees does CardioGenics have?

CardioGenics employs 4 workers across the globe.

What is CardioGenics' official website?

The official website for CardioGenics is www.cardiogenics.com.

Where are CardioGenics' headquarters?

CardioGenics is headquartered at 6295 Northam Drive Unit 8, Mississauga A6, L4V 1W8.

How can I contact CardioGenics?

CardioGenics' mailing address is 6295 Northam Drive Unit 8, Mississauga A6, L4V 1W8. The company can be reached via phone at (905) 673-8501 or via email at [email protected]

This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.